img

Global Tardive Dyskinesia (TD) Treatment Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Tardive Dyskinesia (TD) Treatment Market Insights, Forecast to 2034

Tardive dyskinesia (TD) treatment includes medical interventions and therapies used to manage the involuntary and repetitive movements associated with tardive dyskinesia, a side effect of certain medications.
Market Analysis and InsightsGlobal Tardive Dyskinesia (TD) Treatment Market
Global Tardive Dyskinesia (TD) Treatment market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Tardive Dyskinesia (TD) Treatment industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
The market for tardive dyskinesia treatment is driven by the demand for effective and safe treatments to alleviate the symptoms of TD and improve patients' quality of life. The market's growth is also influenced by ongoing research in neurology and the development of targeted therapies for movement disorders.
Report Covers
This report presents an overview of global Tardive Dyskinesia (TD) Treatment market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Tardive Dyskinesia (TD) Treatment market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Teva Pharma
Biogen
Johnson & Johnson
GlaxoSmithKline
Neurocrine Biosciences
Pfizer
Novartis
Sanofi
AstraZeneca
Bayer AG
Segment by Type
Valbenazine
Amantadine
Tetrabenazine
Clonazepam

Segment by Application


Hospitals
Clinics
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Tardive Dyskinesia (TD) Treatment introduction, etc. Tardive Dyskinesia (TD) Treatment Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Tardive Dyskinesia (TD) Treatment
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Valbenazine
1.2.3 Amantadine
1.2.4 Tetrabenazine
1.2.5 Clonazepam
1.3 Market by Application
1.3.1 Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Tardive Dyskinesia (TD) Treatment Market Perspective (2018-2029)
2.2 Global Tardive Dyskinesia (TD) Treatment Growth Trends by Region
2.2.1 Tardive Dyskinesia (TD) Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Tardive Dyskinesia (TD) Treatment Historic Market Size by Region (2018-2024)
2.2.3 Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Region (2024-2029)
2.3 Tardive Dyskinesia (TD) Treatment Market Dynamics
2.3.1 Tardive Dyskinesia (TD) Treatment Industry Trends
2.3.2 Tardive Dyskinesia (TD) Treatment Market Drivers
2.3.3 Tardive Dyskinesia (TD) Treatment Market Challenges
2.3.4 Tardive Dyskinesia (TD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Tardive Dyskinesia (TD) Treatment by Players
3.1.1 Global Tardive Dyskinesia (TD) Treatment Revenue by Players (2018-2024)
3.1.2 Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Tardive Dyskinesia (TD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Tardive Dyskinesia (TD) Treatment, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Tardive Dyskinesia (TD) Treatment Market Concentration Ratio
3.4.1 Global Tardive Dyskinesia (TD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tardive Dyskinesia (TD) Treatment Revenue in 2022
3.5 Global Key Players of Tardive Dyskinesia (TD) Treatment Head office and Area Served
3.6 Global Key Players of Tardive Dyskinesia (TD) Treatment, Product and Application
3.7 Global Key Players of Tardive Dyskinesia (TD) Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Tardive Dyskinesia (TD) Treatment Breakdown Data by Type
4.1 Global Tardive Dyskinesia (TD) Treatment Historic Market Size by Type (2018-2024)
4.2 Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Type (2024-2029)
5 Tardive Dyskinesia (TD) Treatment Breakdown Data by Application
5.1 Global Tardive Dyskinesia (TD) Treatment Historic Market Size by Application (2018-2024)
5.2 Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Tardive Dyskinesia (TD) Treatment Market Size (2018-2029)
6.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Type
6.2.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024)
6.2.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029)
6.2.3 North America Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
6.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Application
6.3.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024)
6.3.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029)
6.3.3 North America Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
6.4 North America Tardive Dyskinesia (TD) Treatment Market Size by Country
6.4.1 North America Tardive Dyskinesia (TD) Treatment Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2018-2024)
6.4.3 North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Tardive Dyskinesia (TD) Treatment Market Size (2018-2029)
7.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type
7.2.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024)
7.2.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029)
7.2.3 Europe Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
7.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application
7.3.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024)
7.3.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029)
7.3.3 Europe Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
7.4 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country
7.4.1 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2018-2024)
7.4.3 Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Tardive Dyskinesia (TD) Treatment Market Size (2018-2029)
8.2 China Tardive Dyskinesia (TD) Treatment Market Size by Type
8.2.1 China Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024)
8.2.2 China Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029)
8.2.3 China Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
8.3 China Tardive Dyskinesia (TD) Treatment Market Size by Application
8.3.1 China Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024)
8.3.2 China Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029)
8.3.3 China Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Tardive Dyskinesia (TD) Treatment Market Size (2018-2029)
9.2 Asia Tardive Dyskinesia (TD) Treatment Market Size by Type
9.2.1 Asia Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024)
9.2.2 Asia Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029)
9.2.3 Asia Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
9.3 Asia Tardive Dyskinesia (TD) Treatment Market Size by Application
9.3.1 Asia Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024)
9.3.2 Asia Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029)
9.3.3 Asia Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
9.4 Asia Tardive Dyskinesia (TD) Treatment Market Size by Region
9.4.1 Asia Tardive Dyskinesia (TD) Treatment Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Tardive Dyskinesia (TD) Treatment Market Size by Region (2018-2024)
9.4.3 Asia Tardive Dyskinesia (TD) Treatment Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type
10.2.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application
10.3.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country
10.4.1 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Teva Pharma
11.1.1 Teva Pharma Company Details
11.1.2 Teva Pharma Business Overview
11.1.3 Teva Pharma Tardive Dyskinesia (TD) Treatment Introduction
11.1.4 Teva Pharma Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.1.5 Teva Pharma Recent Developments
11.2 Biogen
11.2.1 Biogen Company Details
11.2.2 Biogen Business Overview
11.2.3 Biogen Tardive Dyskinesia (TD) Treatment Introduction
11.2.4 Biogen Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.2.5 Biogen Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Details
11.3.2 Johnson & Johnson Business Overview
11.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Introduction
11.3.4 Johnson & Johnson Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.3.5 Johnson & Johnson Recent Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Details
11.4.2 GlaxoSmithKline Business Overview
11.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Introduction
11.4.4 GlaxoSmithKline Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.4.5 GlaxoSmithKline Recent Developments
11.5 Neurocrine Biosciences
11.5.1 Neurocrine Biosciences Company Details
11.5.2 Neurocrine Biosciences Business Overview
11.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Introduction
11.5.4 Neurocrine Biosciences Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.5.5 Neurocrine Biosciences Recent Developments
11.6 Pfizer
11.6.1 Pfizer Company Details
11.6.2 Pfizer Business Overview
11.6.3 Pfizer Tardive Dyskinesia (TD) Treatment Introduction
11.6.4 Pfizer Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.6.5 Pfizer Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Tardive Dyskinesia (TD) Treatment Introduction
11.7.4 Novartis Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.7.5 Novartis Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Tardive Dyskinesia (TD) Treatment Introduction
11.8.4 Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.8.5 Sanofi Recent Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Introduction
11.9.4 AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.9.5 AstraZeneca Recent Developments
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Tardive Dyskinesia (TD) Treatment Introduction
11.10.4 Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
11.10.5 Bayer AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Valbenazine
Table 3. Key Players of Amantadine
Table 4. Key Players of Tetrabenazine
Table 5. Key Players of Clonazepam
Table 6. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 7. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 8. Global Tardive Dyskinesia (TD) Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Tardive Dyskinesia (TD) Treatment Market Share by Region (2018-2024)
Table 10. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 11. Global Tardive Dyskinesia (TD) Treatment Market Share by Region (2024-2029)
Table 12. Tardive Dyskinesia (TD) Treatment Market Trends
Table 13. Tardive Dyskinesia (TD) Treatment Market Drivers
Table 14. Tardive Dyskinesia (TD) Treatment Market Challenges
Table 15. Tardive Dyskinesia (TD) Treatment Market Restraints
Table 16. Global Tardive Dyskinesia (TD) Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Tardive Dyskinesia (TD) Treatment Revenue Share by Players (2018-2024)
Table 18. Global Top Tardive Dyskinesia (TD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment as of 2022)
Table 19. Global Tardive Dyskinesia (TD) Treatment Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Tardive Dyskinesia (TD) Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Tardive Dyskinesia (TD) Treatment, Headquarters and Area Served
Table 22. Global Key Players of Tardive Dyskinesia (TD) Treatment, Product and Application
Table 23. Global Key Players of Tardive Dyskinesia (TD) Treatment, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2018-2024)
Table 27. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 28. Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2024-2029)
Table 29. Global Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Tardive Dyskinesia (TD) Treatment Revenue Share by Application (2018-2024)
Table 31. Global Tardive Dyskinesia (TD) Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 32. Global Tardive Dyskinesia (TD) Treatment Revenue Share by Application (2024-2029)
Table 33. North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 35. North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 37. North America Tardive Dyskinesia (TD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 38. North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Tardive Dyskinesia (TD) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 40. Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 42. Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 44. Europe Tardive Dyskinesia (TD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Tardive Dyskinesia (TD) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 47. China Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 49. China Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 51. Asia Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 53. Asia Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 55. Asia Tardive Dyskinesia (TD) Treatment Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 56. Asia Tardive Dyskinesia (TD) Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Tardive Dyskinesia (TD) Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Type (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Application (2024-2029) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 63. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 65. Teva Pharma Company Details
Table 66. Teva Pharma Business Overview
Table 67. Teva Pharma Tardive Dyskinesia (TD) Treatment Product
Table 68. Teva Pharma Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 69. Teva Pharma Recent Developments
Table 70. Biogen Company Details
Table 71. Biogen Business Overview
Table 72. Biogen Tardive Dyskinesia (TD) Treatment Product
Table 73. Biogen Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 74. Biogen Recent Developments
Table 75. Johnson & Johnson Company Details
Table 76. Johnson & Johnson Business Overview
Table 77. Johnson & Johnson Tardive Dyskinesia (TD) Treatment Product
Table 78. Johnson & Johnson Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 79. Johnson & Johnson Recent Developments
Table 80. GlaxoSmithKline Company Details
Table 81. GlaxoSmithKline Business Overview
Table 82. GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Product
Table 83. GlaxoSmithKline Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 84. GlaxoSmithKline Recent Developments
Table 85. Neurocrine Biosciences Company Details
Table 86. Neurocrine Biosciences Business Overview
Table 87. Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Product
Table 88. Neurocrine Biosciences Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 89. Neurocrine Biosciences Recent Developments
Table 90. Pfizer Company Details
Table 91. Pfizer Business Overview
Table 92. Pfizer Tardive Dyskinesia (TD) Treatment Product
Table 93. Pfizer Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 94. Pfizer Recent Developments
Table 95. Novartis Company Details
Table 96. Novartis Business Overview
Table 97. Novartis Tardive Dyskinesia (TD) Treatment Product
Table 98. Novartis Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 99. Novartis Recent Developments
Table 100. Sanofi Company Details
Table 101. Sanofi Business Overview
Table 102. Sanofi Tardive Dyskinesia (TD) Treatment Product
Table 103. Sanofi Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 104. Sanofi Recent Developments
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Tardive Dyskinesia (TD) Treatment Product
Table 108. AstraZeneca Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 109. AstraZeneca Recent Developments
Table 110. Bayer AG Company Details
Table 111. Bayer AG Business Overview
Table 112. Bayer AG Tardive Dyskinesia (TD) Treatment Product
Table 113. Bayer AG Revenue in Tardive Dyskinesia (TD) Treatment Business (2018-2024) & (US$ Million)
Table 114. Bayer AG Recent Developments
Table 115. Research Programs/Design for This Report
Table 116. Key Data Information from Secondary Sources
Table 117. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Tardive Dyskinesia (TD) Treatment Market Share by Type: 2022 VS 2029
Figure 3. Valbenazine Features
Figure 4. Amantadine Features
Figure 5. Tetrabenazine Features
Figure 6. Clonazepam Features
Figure 7. Global Tardive Dyskinesia (TD) Treatment Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 8. Global Tardive Dyskinesia (TD) Treatment Market Share by Application: 2022 VS 2029
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Others Case Studies
Figure 12. Tardive Dyskinesia (TD) Treatment Report Years Considered
Figure 13. Global Tardive Dyskinesia (TD) Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 14. Global Tardive Dyskinesia (TD) Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Tardive Dyskinesia (TD) Treatment Market Share by Region: 2022 VS 2029
Figure 16. Global Tardive Dyskinesia (TD) Treatment Market Share by Players in 2022
Figure 17. Global Top Tardive Dyskinesia (TD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tardive Dyskinesia (TD) Treatment as of 2022)
Figure 18. The Top 10 and 5 Players Market Share by Tardive Dyskinesia (TD) Treatment Revenue in 2022
Figure 19. North America Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. North America Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
Figure 21. North America Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
Figure 22. North America Tardive Dyskinesia (TD) Treatment Market Share by Country (2018-2029)
Figure 23. United States Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. Canada Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Europe Tardive Dyskinesia (TD) Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 26. Europe Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
Figure 27. Europe Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
Figure 28. Europe Tardive Dyskinesia (TD) Treatment Market Share by Country (2018-2029)
Figure 29. Germany Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. France Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. U.K. Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Italy Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Russia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Nordic Countries Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. China Tardive Dyskinesia (TD) Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 36. China Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
Figure 37. China Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
Figure 38. Asia Tardive Dyskinesia (TD) Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 39. Asia Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
Figure 40. Asia Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
Figure 41. Asia Tardive Dyskinesia (TD) Treatment Market Share by Region (2018-2029)
Figure 42. Japan Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. South Korea Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. China Taiwan Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Southeast Asia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. India Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. Australia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Size YoY (2018-2029) & (US$ Million)
Figure 49. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Share by Type (2018-2029)
Figure 50. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Share by Application (2018-2029)
Figure 51. Middle East, Africa, and Latin America Tardive Dyskinesia (TD) Treatment Market Share by Country (2018-2029)
Figure 52. Brazil Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Mexico Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Turkey Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. Saudi Arabia Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Israel Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. GCC Countries Tardive Dyskinesia (TD) Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Teva Pharma Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 59. Biogen Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 60. Johnson & Johnson Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 61. GlaxoSmithKline Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 62. Neurocrine Biosciences Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 63. Pfizer Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 64. Novartis Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 65. Sanofi Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 67. Bayer AG Revenue Growth Rate in Tardive Dyskinesia (TD) Treatment Business (2018-2024)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries